)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
ScandiDos
ScandiDos (SDOS) investor relations material
ScandiDos Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary17 Sep, 2026
Executive summary
Sales declined sharply in Q1 26/27 due to significant project delays at customer sites, shifting planned deliveries and impacting revenue by 46% year-over-year.
The quarter is seasonally weak, but also saw important milestones: a successful product launch and a fully subscribed rights issue raising 12.8 MSEK before costs.
Leadership transition occurred as the CEO stepped down, with an interim CEO appointed.
Financial highlights
Net sales for Q1 26/27 were 6.2 MSEK, down from 11.5 MSEK in Q1 25/26, a 46% decrease year-over-year.
Gross margin improved to 82% from 75% year-over-year.
EBITDA was -6.2 MSEK, down from -1.6 MSEK in the prior year, with an EBITDA margin of -100%.
Net result was -6.9 MSEK, compared to -2.2 MSEK in Q1 25/26.
Earnings per share (basic) was -0.10 SEK, versus -0.04 SEK year-over-year.
Cash flow from operations was 1.0 MSEK, up from 0.5 MSEK in Q1 25/26.
Cash and cash equivalents at period end were 16.0 MSEK, up from 9.5 MSEK year-over-year.
Outlook and guidance
Focus remains on accelerating delayed projects and improving delivery pace.
The new Delta4 SRS Pro product is expected to drive future growth after regulatory approvals.
Short-term focus is on sales recovery; long-term on leveraging technical strengths for profitable growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ScandiDos
- Q4 returned to profitability, with new product launches and a rights issue to boost future growth.SDOS
Q4 25/26 - Revenue fell 23% year-over-year due to project delays, but business fundamentals remain stable.SDOSQ3 25/26
- Returned to profitability in Q2 with strong gross margin, despite lower sales and takeover bid activity.SDOSQ2 25/26
- Revenue fell 9% year-over-year, with negative EBITDA and net loss, but gross margin stayed high.SDOSQ1 25/26
- Profitability returned on modest sales growth, with cost savings and strong Japanese sales driving results.SDOSQ4 24/25
- Profitability improved with positive net income and strong Asian sales, despite lower cash flow.SDOSQ2 24/25
- Sales growth and cost savings delivered positive EBITDA and improved net result.SDOSQ1 24/25
- Revenue fell and losses widened due to delayed orders and one-time costs, but capital was raised.SDOSQ4 23/24
- Profitability improved sharply on cost savings, with Asia driving sales growth.SDOSQ3 24/25
Next ScandiDos earnings date
Q2 26/2715 Dec, 2026
ScandiDos
Next ScandiDos earnings date
Q2 26/2715 Dec, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
ScandiDos AB develops and provides advanced measurement systems and software for quality assurance and validation in radiation therapy. The company's Delta4 Family product line is designed to meet the rigorous demands of new dynamic and modulated treatments. ScandiDos serves the medical equipment sector with a focus on ensuring precise dosimetry and QA for modern radiation therapy techniques. ScandiDos is headquartered in Uppsala, Sweden, and its shares are listed on the Stockholm Stock Exchange.